The estimated Net Worth of Thomas A. Hurwich is at least $13.5 Millón dollars as of 28 February 2017. Thomas Hurwich owns over 2,311 units of Abbvie Inc stock worth over $13,091,237 and over the last 12 years Thomas sold ABBV stock worth over $396,299.
Thomas has made over 12 trades of the Abbvie Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Thomas sold 2,311 units of ABBV stock worth $143,028 on 28 February 2017.
The largest trade Thomas's ever made was exercising 11,503 units of Abbvie Inc stock on 14 August 2013 worth over $316,678. On average, Thomas trades about 2,745 units every 62 days since 2013. As of 28 February 2017 Thomas still owns at least 67,276 units of Abbvie Inc stock.
You can see the complete history of Thomas Hurwich stock trades at the bottom of the page.
Thomas's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 12 years, insiders at Abbvie Inc have traded over $324,915,370 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 . The most active insiders traders include Richard A Gonzalez, Frederick H Waddell y Glenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $7,529,855. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth $12,403,580.
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
Abbvie Inc executives and other stock owners filed with the SEC include: